Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) EBT (2018 - 2026)

Bicycle Therapeutics (BCYC) has disclosed EBT for 9 consecutive years, with -$60.7 million as the latest value for Q1 2026.

  • For Q1 2026, EBT rose 1.92% year-over-year to -$60.7 million; the TTM value through Mar 2026 reached -$224.3 million, down 670.31%, while the annual FY2025 figure was -$225.5 million, 3977.81% down from the prior year.
  • EBT hit -$60.7 million in Q1 2026 for Bicycle Therapeutics, down from -$25.5 million in the prior quarter.
  • Across five years, EBT topped out at $126.7 million in Q4 2024 and bottomed at -$79.2 million in Q2 2025.
  • Average EBT over 5 years is -$34.1 million, with a median of -$39.7 million recorded in 2024.
  • Year-over-year, EBT skyrocketed 341.05% in 2024 and then crashed 129.78% in 2025.
  • Bicycle Therapeutics' EBT stood at -$32.4 million in 2022, then tumbled by 62.04% to -$52.6 million in 2023, then surged by 341.05% to $126.7 million in 2024, then tumbled by 120.16% to -$25.5 million in 2025, then tumbled by 137.51% to -$60.7 million in 2026.
  • According to Business Quant data, EBT over the past three periods came in at -$60.7 million, -$25.5 million, and -$58.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.